Automation- and miniaturization of organoid assays for drug screening


Learn how to develop an automated organoid assay in 1536 well-format for drug screening and reduce the cost of the assay.



Presenter: Dr. Tijmen Booij, NEXUS, ETH Zürich | UPM Biomedicals 8th Annual Conference, 2022

Tijmen is senior screening specialist at the ETH Zurich core facility NEXUS Personalized Health Technologies in Switzerland. He develops high-throughput screening assays with a particular focus on assay miniaturization for advanced cell systems. Tijmen studied bio-pharmaceutical sciences at Leiden University in the Netherlands, where he also obtained his PhD degree. During his studies, he used lab-automation equipment and 3D-cell culture models to develop and optimize high-throughput and high-content screening assays.